Showing 2,581 - 2,600 results of 4,407 for search '"pharmaceutical"', query time: 0.05s Refine Results
  1. 2581
  2. 2582
  3. 2583
  4. 2584
  5. 2585

    The Value Chain of Moringa oleifera Plant and the Process of Producing Its Biodiesel in Ghana by Mohammed Takase, Paul Kwame Essandoh, Richard Kwadzo Asare, Kizzie-Hayford Nazir

    Published 2022-01-01
    “…Dubbed as the “Miracle Tree,” Moringa has a number of nutritional, pharmaceutical, and cosmetic applications. It is also used as a cure for diabetes and various forms of cancer. …”
    Get full text
    Article
  6. 2586
  7. 2587

    Leading causes of fever in patients with liver function disorders by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya

    Published 2010-02-01
    “…If the site of infection is not detected, it is necessary to keep in mind the option of development of non-infectious fever within acute phase reaction, neoplastic process or reaction to applied pharmaceutical agents.Conclusion. At development of fever at patients with liver failure carrying out differential diagnostics of the causes of body temperature elevation is necessary that allows more differentiated approaches to treatment.…”
    Get full text
    Article
  8. 2588

    Data Envelopment Analysis and Efficiency of Firms: A Goal Programming Approach by Seyyed Ahmad Edalatpanah, Ramin Godarzi Karim, Bardia Khalilian, Sara Partouvi

    Published 2020-05-01
    “…Methodology: In this study, three industries- banking, petrochemical, and pharmaceutical- were studied to determine efficient companies. …”
    Get full text
    Article
  9. 2589
  10. 2590
  11. 2591

    Up-to-date approaches to treatment of the functional constipation at children by V. F. Privorotsky, N. Ye. Luppova

    Published 2009-02-01
    “…In the literature there are data indicating safety and high performance of this pharmaceutical agent.Conclusion. Rome criteria of IBS are applicable only in relation to children of middle and senior school age. …”
    Get full text
    Article
  12. 2592

    How to improve psychiatric nosography in the XXI century: a phenomenologist”s viewpoint by Giovanni Stanghellini

    Published 2025-01-01
    “…Classifications of mental disorders reflect much more the minds of psychiatrists than the patients’ minds since these classifications are more focused on the interests of stakeholders (including governmental agencies, advocacy groups, medical insurance, and pharmaceutical companies) than on the experiences of patients. …”
    Get full text
    Article
  13. 2593
  14. 2594
  15. 2595
  16. 2596

    Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations by Sherif Elhosseiny, Hassan Al Moussawi, Jean M. Chalhoub, James Lafferty, Liliane Deeb

    Published 2019-01-01
    “…The introduction of Direct Oral Anticoagulants (DOACs) to the pharmaceutical market provided patients and clinicians with novel convenient and safe options of anticoagulation. …”
    Get full text
    Article
  17. 2597

    Essential oils – a review of the natural evolution of applications and some future perspectives by Stanislava Ivanova, Yana Gvozdeva, Radiana Staynova, Daniela Grekova-Kafalova, Vanya Nalbantova, Niko Benbassat, Nina Koleva, Kalin Ivanov

    Published 2025-01-01
    “…Currently, EOs represent not only an important part of the contemporary pharmaceutical and cosmetic industry but are also considered as sources for novel drug candidates. …”
    Get full text
    Article
  18. 2598

    The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

    Published 2021-12-01
    “… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
    Get full text
    Article
  19. 2599
  20. 2600

    The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

    Published 2021-12-01
    “… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
    Get full text
    Article